Jane Street’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,607
| Closed | -$408K | – | 12129 |
|
|
2026
Q1 | $408K | Buy |
+13,607
| New | +$451K | ﹤0.01% | 8514 |
|
|
2025
Q4 | – | Sell |
-9,049
| Closed | -$313K | – | 11603 |
|
|
2025
Q3 | $313K | Sell |
9,049
-21,726
| -71% | -$695K | ﹤0.01% | 8812 |
|
|
2025
Q2 | $861K | Sell |
30,775
-80,008
| -72% | -$2.14M | ﹤0.01% | 5895 |
|
|
2025
Q1 | $2.78M | Buy |
110,783
+99,646
| +895% | +$2.52M | ﹤0.01% | 3827 |
|
|
2024
Q4 | $306K | Buy |
+11,137
| New | +$310K | ﹤0.01% | 7705 |
|
|
2024
Q1 | – | Sell |
-42,682
| Closed | -$1.74M | – | 9519 |
|
|
2023
Q4 | $1.74M | Buy |
+42,682
| New | +$1.57M | ﹤0.01% | 4585 |
|
|
2022
Q4 | – | Sell |
-66,424
| Closed | -$2.83M | – | 9477 |
|
|
2022
Q3 | $2.83M | Sell |
66,424
-73,810
| -53% | -$3.78M | ﹤0.01% | 3556 |
|
|
2022
Q2 | $7.83M | Buy |
140,234
+121,655
| +655% | +$7.21M | ﹤0.01% | 2038 |
|
|
2022
Q1 | $1.15M | Buy |
18,579
+14,860
| +400% | +$910K | ﹤0.01% | 5838 |
|
|
2021
Q4 | $205K | Sell |
3,719
-2,133
| -36% | -$111K | ﹤0.01% | 8789 |
|
|
2021
Q3 | $308K | Sell |
5,852
-6,316
| -52% | -$375K | ﹤0.01% | 8127 |
|
|
2021
Q2 | $838K | Sell |
12,168
-4,773
| -28% | -$364K | ﹤0.01% | 6217 |
|
|
2021
Q1 | $1.31M | Sell |
16,941
-27,392
| -62% | -$2.52M | ﹤0.01% | 4927 |
|
|
2020
Q4 | $4.39M | Buy |
44,333
+13,370
| +43% | +$1.63M | ﹤0.01% | 2299 |
|
|
2020
Q3 | $4.39M | Sell |
30,963
-25,996
| -46% | -$4.33M | ﹤0.01% | 1993 |
|
|
2020
Q2 | $11.2M | Buy |
56,959
+45,752
| +408% | +$9.48M | 0.01% | 1110 |
|
|
2020
Q1 | $2.2M | Sell |
11,207
-84,395
| -88% | -$18.2M | ﹤0.01% | 1931 |
|
|
2019
Q4 | $19.8M | Buy |
95,602
+36,008
| +60% | +$6.66M | 0.03% | 381 |
|
|
2019
Q3 | $9.1M | Buy |
59,594
+51,147
| +606% | +$8.38M | 0.02% | 644 |
|
|
2019
Q2 | $1.09M | Buy |
+8,447
| New | +$1M | ﹤0.01% | 2590 |
|
|
2019
Q1 | – | Sell |
-54,536
| Closed | -$5M | – | 5231 |
|
|
2018
Q4 | $5M | Sell |
54,536
-130,733
| -71% | -$13.3M | 0.01% | 952 |
|
|
2018
Q3 | $20.8M | Buy |
185,269
+126,277
| +214% | +$13.3M | 0.04% | 322 |
|
|
2018
Q2 | $5.44M | Sell |
58,992
-31,594
| -35% | -$3.07M | 0.01% | 971 |
|
|
2018
Q1 | $9.04M | Sell |
90,586
-46,626
| -34% | -$5.03M | 0.02% | 593 |
|
|
2017
Q4 | $12.9M | Buy |
137,212
+63,958
| +87% | +$6.05M | 0.04% | 418 |
|
|
2017
Q3 | $7.45M | Sell |
73,254
-45,885
| -39% | -$4.01M | 0.02% | 637 |
|
|
2017
Q2 | $9.12M | Buy |
+119,139
| New | +$10M | 0.03% | 497 |
|
|
2015
Q4 | – | Sell |
-25,984
| Closed | -$1.06M | – | 4160 |
|
|
2015
Q3 | $1.06M | Buy |
+25,984
| New | +$1.5M | 0.01% | 1586 |
|
Other funds holding LKFT
GS
TCM
MAP
PM
EC
DCM
Jane Street's LKFT Position: Q2 2026 in Review
Jane Street sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 13,607 shares — an estimated $408K sold.
Jane Street first reported a position in LKFT in Q3 2015 and held it in 28 quarters. The position peaked at $20.8M in Q3 2018. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Jane Street reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 13,607 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $408K.
- Jane Street first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 28 quarters.
- Jane Street's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.8M in Q3 2018.
- 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.